Year archive

IMMUTEP LIMITED — 2015 filings

All 97 regulatory filings released by IMMUTEP LIMITED (IMM) in 2015, sourced directly from the official regulator.

97 Filings

2015 Period

2015 filings (97)

Filing	Released	Lang
Appendix 3B 13 pages 896.7KB Capital/Financing Update	2015-12-28	English
Prima initiates phase IIb study in metastatic breast cancer 4 pages 283.7KB Regulatory Filings	2015-12-21	English
Prima Progresses Japanese Collaboration 3 pages 342.4KB Capital/Financing Update	2015-12-10	English
$420k R&D Tax Incentive Refund Received 1 page 245. Regulatory Filings	2015-11-25	English
2015 AGM Address to Shareholders 2 pages 101.9KB AGM Information	2015-11-24	English
2015 CEO's Presentation 25 pages 1.2MB AGM Information	2015-11-24	English
Results of Meeting 2 pages 330.0KB Declaration of Voting Results & Voting Rights Announcements	2015-11-24	English
Prima Newsletter 8 pages 335.9KB Investor Presentation	2015-11-22	English
Prima unveils Phase I combination study of IMP321 3 pages 263.7KB Regulatory Filings	2015-11-17	English
Prima to present at Immune Checkpoint Inhibitor meeting 2 pages 250.7KB Investor Presentation	2015-11-04	English
Annual Report filed on Form 20-F with SEC 135 pages 940.8KB Annual Report	2015-11-01	English
Prima announces A$2m investment from institutional investor 1 Capital/Financing Update	2015-10-29	English
Cleansing Notice & Appendix 3B 14 pages 916.3KB Capital/Financing Update	2015-10-29	English
Belgian regulatory approval received for AIPAC trial 3 pages 267.4KB Regulatory Filings	2015-10-26	English
Notice of Annual General Meeting/Proxy Form 24 pages 1.4MB AGM Information	2015-10-21	English
Annual Report to Shareholders 62 pages 2.0MB Annual Report	2015-10-21	English
Appendix 4G 14 pages 274.5KB Governance Information	2015-10-21	English
Change of Address 1 page 231.1KB Regulatory Filings	2015-10-18	English
Information Required Under Listing Rule 3.10.5A 1 p Share Issue/Capital Change	2015-10-13	English
Cleansing Notice & Appendix 3B 14 pages 917.6KB Capital/Financing Update	2015-10-12	English
Prima announces A$1.55m investment from Nyenburg 2 pages 258.2KB Capital/Financing Update	2015-10-12	English
Prima receives grant from the Saxony Development Bank 1 Capital/Financing Update	2015-10-08	English
Appendix 4C - quarterly 5 pages 402.1KB Interim / Quarterly Report	2015-10-07	English
Change of Director's Interest Notice 3 pages 40.2KB Director's Dealing	2015-10-01	English
Change of Director's Interest Notice 4 pages 48.6KB Director's Dealing	2015-10-01	English
Appendix 3B & Cleansing Notice 15 pages 921.7KB Share Issue/Capital Change	2015-09-30	English
Prima to present at Leerink Partners Rare Disease Roundtable 1 Investor Presentation	2015-09-24	English
Response to ASX Price Query 1 page 81.7KB Regulatory Filings	2015-09-02	English
Appendix 4E & 2015 Full Year Statutory Accounts 92 pages 886.0KB Regulatory Filings	2015-08-27	English
Prima to present at Rodman & Renshaw Conference 2 pages 288.4KB Regulatory Filings	2015-08-27	English
Milestone payment to be received from Novartis 2 pages 284.6KB Capital/Financing Update	2015-08-13	English
Appendix 3B 15 pages 684.0KB Capital/Financing Update	2015-08-04	English
Change of Director's Interest Notice 4 pages 225.2KB Director's Dealing	2015-08-04	English
Termination of Bergen Investment Facility 2 pages 287.1KB Capital/Financing Update	2015-08-03	English
Warrants Prospectus 27 pages 486.8KB Capital/Financing Update	2015-08-03	English
Appendix 3B 14 pages 661.9KB Share Issue/Capital Change	2015-08-03	English
Section 708A(12C)(e) Cleansing Notice 14 pages 362.5KB Capital/Financing Update	2015-08-03	English
Cleansing Notice 1 page 261.0KB Regulatory Filings	2015-08-03	English
Change of Director's Interest Notice 2 pages 401.1KB Director's Dealing	2015-08-02	English
Change of Director's Interest Notice 2 pages 400.2KB Director's Dealing	2015-08-02	English
2015 EGM Chairman's Address 2 pages 210.8KB AGM Information	2015-07-30	English
2015 EGM CEO's Presentation 16 pages 602.3KB Investor Presentation	2015-07-30	English
Results of Meeting 3 pages 322.8KB Declaration of Voting Results & Voting Rights Announcements	2015-07-30	English
Appendix 3B 13 pages 653.6KB Capital/Financing Update	2015-07-29	English
Appendix 4C - quarterly 5 pages 135.8KB Interim / Quarterly Report	2015-07-27	English
Prima raises A$10m through Share Purchase Plan 2 pages 284.7KB Capital/Financing Update	2015-07-23	English
Response to ASX Aware Letter 6 pages 427.4KB Regulatory Filings	2015-07-12	English
Prima Newsletter 8 pages 1.5MB Investor Presentation	2015-07-09	English
Share Purchase Plan Offer Documents 14 pages 356.9KB Capital/Financing Update	2015-07-09	English
Positive scientific advice received from the EMA for IMP321 3 pages 298.8KB Capital/Financing Update	2015-07-06	English
Share Purchase Plan 3 pages 305.5KB Capital/Financing Update	2015-07-06	English
Notice of Extraordinary General Meeting/Proxy Form 127 pages 2.2MB AGM Information	2015-06-28	English
Appendix 3B 13 pages 651.5KB Capital/Financing Update	2015-06-22	English
Prima to present at Bioshares Biotech Summit 2 pages 287.4KB Investor Presentation	2015-06-11	English
Cleansing Notice 1 page 259.0KB Share Issue/Capital Change	2015-06-11	English
Prima receives research tax credit cash rebate in France 2 pages 288.7KB Capital/Financing Update	2015-06-10	English
Appendix 3B 13 pages 650.9KB Capital/Financing Update	2015-06-10	English
Appendix 3B 13 pages 651.6KB Capital/Financing Update	2015-06-09	English
Ceasing to be a substantial holder 2 pages 58.6KB Regulatory Filings	2015-06-04	English
Appendix 3B 13 pages 690.8KB Capital/Financing Update	2015-06-04	English
Appendix 3B 13 pages 651.3KB Capital/Financing Update	2015-06-03	English
Prima to maintain NASDAQ listing 2 pages 283.6KB Regulatory Filings	2015-06-03	English
Becoming a substantial holder - J.P. Morgan 6 pages 579.4KB Regulatory Filings	2015-06-02	English
Ceasing to be a substantial holder - J.P. Morgan 5 pages 503.6KB Regulatory Filings	2015-06-02	English
Cleansing Notice & Appendix 3B 14 pages 718.0KB Capital/Financing Update	2015-06-02	English
Change in substantial holding 3 pages 81.6KB Regulatory Filings	2015-06-01	English
Appendix 3B 13 pages 651.8KB Capital/Financing Update	2015-06-01	English
Becoming a substantial holder 2 pages 673.2KB Regulatory Filings	2015-05-28	English
Prima announces new IP for IMP 321 3 pages 306.2KB Regulatory Filings	2015-05-28	English
Appendix 3B 13 pages 651.7KB Capital/Financing Update	2015-05-28	English
Appendix 3B 13 pages 651.7KB Capital/Financing Update	2015-05-27	English
Cleansing Notice & Appendix 3B 14 pages 684.2KB Capital/Financing Update	2015-05-26	English
Becoming a substantial holder 2 pages 76.7KB Regulatory Filings	2015-05-26	English
Appendix 3B 13 pages 651.2KB Capital/Financing Update	2015-05-25	English
Prima to Commercialise Database Management Platform 2 pages 213.4KB Regulatory Filings	2015-05-24	English
Prima to Present at Proactive Investors Forums 2 pages 209.7KB Investor Presentation	2015-05-24	English
Appendix 3B 13 pages 652.6KB Capital/Financing Update	2015-05-24	English
Prima 2015 Capital Raising Presentation 23 pages 882.9KB Investor Presentation	2015-05-19	English
Prima May 2015 Corporate Presentation 49 pages 2.0MB Investor Presentation	2015-05-19	English
Cleansing Notice 1 page 199.7KB Capital/Financing Update	2015-05-19	English
CVac shows overall survival benefit 3 pages 312.0KB Regulatory Filings	2015-05-18	English
Appendix 3B 13 pages 923.2KB Capital/Financing Update	2015-05-14	English
Information Required Under Listing Rule 3.10.5A 1 p Capital/Financing Update	2015-05-14	English
Prima Biomed Announces A$15m Investment from Ridgeback 4 pages 117.2KB Capital/Financing Update	2015-05-13	English
Prima announces Japanese Collaboration 2 pages 97.8KB Regulatory Filings	2015-05-10	English
Prima to present at Canary Networks Investor Roadshow 1 Investor Presentation	2015-04-28	English
Appendix 4C - quarterly 6 pages 334.0KB Interim / Quarterly Report	2015-04-15	English
Introductory Investor Presentation 50 pages 1.5MB Investor Presentation	2015-02-26	English
Detailed Investor Presentation 50 pages 1.2MB Investor Presentation	2015-02-26	English
Prima BioMed Prioritising IMP 321 3 pages 217.5KB Capital/Financing Update	2015-02-26	English
Half Yearly Report and Accounts 27 pages 380.7KB Regulatory Filings	2015-02-26	English
Appendix 4C - quarterly 6 pages 196.6KB Interim / Quarterly Report	2015-01-29	English
Financial milestone payment to be received from GSK 2 pages 283.7KB Capital/Financing Update	2015-01-26	English
Cleansing Notice & Appendix 3B 14 pages 295.4KB Capital/Financing Update	2015-01-22	English
Stuart Roberts appointed Global Head of Investor Relations 2 pages 217.4KB Board/Management Information	2015-01-19	English
R&D Tax Incentive Refund Received 1 page 116.3KB Regulatory Filings	2015-01-19	English
Change of Director's Interest Notice 3 pages 286.5KB Director's Dealing	2015-01-06	English

Filings by year

2026 29 filings
2025 65 filings
2024 98 filings
2023 83 filings
2022 84 filings
2021 109 filings
2020 111 filings
2019 84 filings
2018 69 filings
2017 6 filings
2016 48 filings
2015 97 filings
2014 72 filings
2013 104 filings
2012 59 filings
2011 113 filings
2010 91 filings
2009 93 filings
2008 41 filings
2007 55 filings
2006 44 filings
2005 56 filings
2004 84 filings
2003 75 filings
2002 10 filings